PET/CT in cancer : an interdisciplinary approach to individualized imaging /
Edited, authored, and reviewed by an expert team of oncologists and nuclear physicians/radiologists, this one-of-a-kind title helps you make the most of the critical role PET/CT plays in cancer staging and therapeutic responses to individualized treatments. Drs. Mohsen Beheshti, Werner Langsteger, a...
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Philadelphia, PA :
Elsevier,
[2018]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover; PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging; PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging; Copyright; Contributors; Preface; Contents; Abbreviations; 1
- Head and Neck Cancers; BACKGROUND; General; Early Clinical Symptoms9; Standard Diagnostic Procedures10; Standard Treatment11-13; Prognostic Factors13-15; Five-Year Survival16; TUMOR CHARACTERISTICS AND TYPICAL BEHAVIOR; Histopathology2,17; N-lymph nodes2; M-distant metastasis2; TNM CLASSIFICATION13,19; Guidelines; EVIDENCE-BASED VIEWPOINTS; COST-EFFECTIVENESS.
- CLINICAL POINT OF VIEWPITFALLS31-35; False Positive; False Negative; DISCUSSION; TEACHING CASES; Case 1: Staging, Laryngeal Cancer; Case 2: Staging, SCC, Base of the Tongue; Case 3: Staging, Sinus Piriform Cancer; Case 4: Cancer of Unknown Primary; Case 5: Staging, Adenoid Cystic Carcinoma; Case 6: Staging, Tonsillar Cancer With Incidental Second Cancer; Case 7: Staging, Oropharyngeal Cancer, Myelodysplastic Syndrome; Case 8: HNSCC, Recurrence; Case 9: Therapy Monitoring, Nasopharyngeal Cancer; Case 10: Staging and Restaging Rhabdomyosarcoma; REFERENCES; 2
- Lung Cancer; BACKGROUND; General1.
- Clinical Signs/Symptoms6Primary Diagnostic Procedures7-12; Standard Treatments13-26; Non-small cell lung cancer; Prognostic Factors27-33; Non-small cell lung cancer; Small cell lung cancer; TUMOR CHARACTERISTICS AND TYPICAL BEHAVIOR; Histopathology1; N-lymph nodes; M-distant metastasis; TNM CLASSIFICATION34,35; Primary Tumor (T); Regional Lymph Nodes (N); Distant Metastasis (M); GUIDELINES; EVIDENCE-BASED VIEWPOINTS; COST-EFFECTIVENESS46,54-56; CLINICAL POINT OF VIEW; Suspected Disease; Initial Diagnosis; Non-small Cell Lung Cancer; Small Cell Lung Cancer.
- Suspected Recurrence After Potentially Curative TherapyMetastatic Disease; Response to Therapy; PITFALLS57-59; False Positive; False Negative; DISCUSSION; Solitary Pulmonary Nodules; Staging Lung Cancer; Prognostic Value; Therapy Monitoring; Detection of Tumor Burden and Planning for Radiation Therapy; Comparison With Other Modalities; Radiopharmaceuticals Beyond FDG; CONCLUSION; TEACHING CASES; Case 1: Staging at SCLC; Case 2: Staging NSCLC-Early Detection of Distant Metastases; Case 3: Staging NSCLC-Atypical Distant Metastases; Case 4: Staging NSCLC-Atypical Distant Metastases.
- Case 5: Staging Lung Cancer-Guiding Biopsy and RadiotherapyCase 6: Staging SCLC-Differentiation of Limited From Extended Stage; Case 7: NSCLC-Recurrence; Case 8: Mesothelioma-Treatment Monitoring; Case 9: Talc Pleurodesis; Case 10: Carcinoid Tumor-Very Low FDG-Avid Malignancies; REFERENCES; 3
- Breast Cancer; BACKGROUND; General1,2; Early Clinical Symptoms1,3; Primary Diagnostic Procedures1,4; Standard Treatment5; Prognostic Factors6; Five-Year Survival7; TUMOR CHARACTERISTICS AND TYPICAL BEHAVIOR; Histopathology8; Distribution and Localization9-11; N-lymph nodes; T-primary.